01
Your market validation is gathering yeses, not insight.
Finding people who like your idea isn't market validation. The research that actually changes what you build, the kind that surfaces the real usage case, the real barrier, the real competitor, is a different process. And it's the process that stops you building the wrong thing at speed.
02
Your evidence is persuasive. But will it hold up to scrutiny?
A deck that wins a room and evidence that satisfies an investor, a commissioner, or a grant panel are different things. If you can't show adoption data, adherence metrics, and a documented methodology, the enthusiasm doesn't convert. We build the insight foundation that closes that gap before it becomes expensive.
03
You're describing the technology. Not the behaviour change.
Digital health products don't fail because the tech doesn't work. They fail because the behaviour around them wasn't accounted for. Clinical culture, implementation pathway, onboarding design, change readiness, these aren't soft considerations. They're the adoption mechanism.
04
The team is scaling faster than the leadership can hold.
The skills that get a founding team to seed aren't the same skills that get a company to Series A. The transition from founder to CEO, managing a growing team, making decisions under pressure, leading through ambiguity, is a specific challenge. One we coach at doctoral depth.